Atlas Trials

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Clinical trial NCT05645744 · TERMINATED

Trial details

NCT number
NCT05645744
Sponsor
Mustang Bio
Status
TERMINATED
Study type
OBSERVATIONAL
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Chronic Lymphocytic Leukemia in RelapseSmall Lymphocytic Lymphoma, RelapsedWaldenstrom's Macroglobulinemia RecurrentFollicular B-cell Non-Hodgkin's LymphomaB-cell Lymphoma RefractoryMantle Cell Lymphoma RecurrentHairy Cell LeukemiaDiffuse Large B Cell LymphomaWaldenstrom's Macroglobulinemia RefractoryMantle Cell Lymphoma Refractory
Start date
2021-09-29
Primary completion
2024-04-12
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.